| Literature DB >> 19560476 |
Martijn G van Koningsbruggen1, Tom Pender, Liana Machado, Robert D Rafal.
Abstract
To investigate the role of the basal ganglia in integrating voluntary and reflexive behaviour, the current study examined the ability of patients with Parkinson's disease to voluntarily control oculomotor reflexes. We measured the size of the fixation offset effect (the reduction in saccadic reaction time when a fixation point is removed) during a block of pro- and a block of anti-saccades. Healthy controls showed the expected reduction of the FOE during the anti-saccades, which results from efforts to suppress reflexive eye movements (a preparatory set characterized by increased internal control and reduced external control). However, there was no reduction of the FOE in the anti-saccade task in Parkinson's patients, indicating that they are impaired in exerting control over oculomotor reflexes.Entities:
Mesh:
Year: 2009 PMID: 19560476 PMCID: PMC2778793 DOI: 10.1016/j.neuropsychologia.2009.06.018
Source DB: PubMed Journal: Neuropsychologia ISSN: 0028-3932 Impact factor: 3.139
| Patient | Sex | Age | Disease duration | UPDRS | Medication |
|---|---|---|---|---|---|
| 1 | F | 69 | 6 | 27/92 | Prarnipexole |
| 2 | M | 64 | 13 | 24/92 | Levodopa-Carbidopa |
| 3 | M | 64 | 12 | 7.5/92 | Ropinerole, Levodopa-Carbidopa |
| 4 | M | 59 | 2 | 6.5/92 | Ropinerole, Rasagiline |
| 5 | F | 70 | 5 | 19.5/92 | Levodopa-Carbidopa, Prarnipexole |
| 6 | M | 67 | 5 | 15/92 | Prarnipexole |
| 7 | M | 77 | 12 | 15192 | Levodopa-Carbidopa, Prarnipexole |
| 8 | M | 62 | 7 | U.5/92 | Levodopa-Carbidopa, Prarnipexole |
| 9 | M | 61 | 17 | 19.5/92 | Prarnipexole, Benserazide, Entacapon |
| 10 | M | 55 | 44 | 3/92 | Prarnipexole |
| 11 | M | 61 | 5 | 16/92 | Levodopa-Carbidopa |
| 12 | F | 18 | 17/92 | Ropinerole, | |
| 13 | M | 63 | 3 | 10/52 | Ropinerole |
| 14 | F | 71 | 3 | 9.5/92 | Levodopa-Carbidopa |
| 15 | F | 71 | 6 | 16.5/92 | Levodopa-Carbidopa, Ropinerole |
| 16 | M | 81 | 11 | 21/92 | Levodopa-Carbidopa |
| 17 | F | 68 | 2 | 30/92 | Levodopa-Carbidopa |
| 18 | M | 72 | 6 | 3/92 | Levodopa-Carbidopa, Prarnipexole |
Fig. 1Mean Saccadic Reaction times for both groups, with the size of the FOE.
Fig. 2The 95%CI of the mean amount of control over oculomotor reflexes (=FOE(Pro-Saccades) − FOE(Anti-Saccades)) for both PD patients and healthy controls.
Fig. 3Mean saccade amplitude for each condition (±1SEM) for both the healthy controls (top panel) and PD patients (bottom panel).
Fig. 4Mean amount of direction errors during the anti-saccade task (±1SEM).